Clinical Trial Update: IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update involving intravitreal triamcinolone acetonide. It investigates monitoring intraocular pressure elevations after topical steroids …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Vitreoretinal Disease

Drugs mentioned

• Triamcinolone acetonide (intravitreal) (triamcinolone acetonide)

Snippet

Sponsor: Hotel Dieu Hospital | Conditions: Vitreoretinal Disease, Ocular Hypertension | Phase 4 | Status: UNKNOWN